CEL-SCI Corp. (CVM) Posts Quarterly Results
CEL-SCI Corp. (NYSE:CVM) announced its earnings results on Tuesday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.13, Analyst Ratings Network reports.
CEL-SCI Corp. (NYSE:CVM) opened at 1.16 on Tuesday. CEL-SCI Corp. has a one year low of $0.53 and a one year high of $2.80. The stock’s 50-day moving average is $1.37 and its 200-day moving average is $1.05. The company’s market cap is $64.9 million. CEL-SCI Corp. also was the target of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 5,323,503 shares, a drop of 19.8% from the April 15th total of 6,635,593 shares. Based on an average trading volume of 866,256 shares, the short-interest ratio is currently 6.1 days. Approximately 9.7% of the shares of the stock are short sold.
CEL-SCI Corporation (NYSE:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.